AVDL(Delisted)
Avadel Pharmaceuticals·NASDAQ
--
--(--)
AVDL Filings
Filing Date
Form Description
Form Type
2026-02-23
Form 15-12G - Securities registration termination [Section 12(g)]
Key Events
2026-02-23 · Key Events
Form 15-12G - Securities registration termination [Section 12(g)]
2026-02-18
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-18 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-18
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-02-18 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17
Form EFFECT - Notice of Effectiveness
2026-02-17 ·
Form EFFECT - Notice of Effectiveness
2026-02-17
Form EFFECT - Notice of Effectiveness
2026-02-17 ·
Form EFFECT - Notice of Effectiveness
2026-02-17
Form EFFECT - Notice of Effectiveness
2026-02-17 ·
Form EFFECT - Notice of Effectiveness
2026-02-17
Form EFFECT - Notice of Effectiveness
2026-02-17 ·
Form EFFECT - Notice of Effectiveness
2026-02-12
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-12 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
